Paul Romer
copied to clipboard

Lots of people who know nothing about molecular genomics make all kinds of confident preditions that it will be impossible to scale up molecular testing for SARS-COV2.

Just for the heck of it, see what a team that knows something has to say.
tweet media

“Given the low cost and scalability of next-generation sequencing, we believe that this method can be affordably scaled to analyze millions of samples per day using existing sequencing infrastructure.”